Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 19 Dec 2023  |  North America  |  Market Research

    Growth Opportunities in US Digital Health Solutions as an Enabler for Value-based Care

    Robust Investments and Disruptive Technological Innovation Transforming Care Delivery

    According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...

    $2,450.00
  2. 30 Mar 2023  |  North America  |  Customer Research

    Global Laboratory Product Purchasing Trends, 2022–2023

    End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending

    Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-o...

    $4,950.00
  3. 03 Feb 2023  |  North America  |  Market Research

    Global Pharmaceutical Continuous Manufacturing Market, Growth Opportunities

    Regulatory Acceptance Propelling Continuous Manufacturing Investments through Partnerships and In-house Expansions

    Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...

    $4,950.00
  4. 03 Dec 2013  |  North America  |  Market Research

    Analysis of the Global Tissue Diagnostics Market

    Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories

    This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forec...

    $10,000.00
  5. 26 Sep 2013  |  North America  |  Market Research

    US Medical Radiopharmaceuticals Market

    New Growth Opportunities Emerge in a Strenuous Market

    This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...

    $4,950.00
  6. 02 Sep 2013  |  North America  |  Customer Research

    Global Analysis of MicroRNA Tools and Services Market

    Evolving microRNA Market Provides an Opportunity for Vendors of qRT-PCR and Functional Tools

    The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteria for purchasing sequencing instruments. Disease-r...

    $10,000.00
  7. 11 Jul 2013  |  North America  |  Tracker

    2012 United States Radiology Directors’ Choice: Medical Imaging Equipment

    Determining Brand Perceptions and Preferences

    The primary objective of this research is to assess the behavior of North American radiology directors as well as their preferences regarding radiology departments use of medical imaging equipment and services. Supporting the primary objective, this research will also: determine titles of medical equipment purchasers (executives, directors, and man...

    $10,000.00
  8. 30 Jun 2013  |  North America  |  Market Research

    Vital Signs - Pointing Towards Point-of-Care Testing - The Next Big Shift

    This issue of Vital Signs published June 30, 2013, provides a global overview of market trends and expected growth of the Point-of-care Testing (POCT) market.

    $1,500.00
  9. 27 Jun 2013  |  North America  |  Market Research

    2013 Global Medical Imaging Equipment Market Outlook

    Positioning for the Future

    This outlook analyzes trends and revenue in the global medical imaging equipment market from 2012 to 2017. The market is segmented by geographic region and by medical imaging modality, with 10 regional and 7 modality segments evaluated. The modalities evaluated are general X-ray, mammographic X-ray, interventional X-ray, CT, ultrasound, MR, and mol...

    $4,950.00
  10. 27 Jun 2013  |  North America  |  Market Research

    Global Mass Spectrometry Market

    Technological Advancements Drive Demand in Diverse Applications

    This research service evaluates the global mass spectrometry market from 2010 to 2017. Regions analyzed include the US, Europe, Asia-Pacific (APAC), and Rest of World (ROW) combined. Technology segments analyzed include single quadrupole LC/MS, tandem LC/MS, time-of-flight LC/MS, and MALDI-TOF-MS. The mature market remains dynamic due to a technolo...

    $4,950.00